Semaglutide Therapy for Alcohol Reduction (STAR)
Clinical trial NCT06015893 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06015893
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-17
- Primary completion
- 2027-03-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.